Next Article in Journal
Conventional Therapeutics in BPDCN Patients—Do They Still Have a Place in the Era of Targeted Therapies?
Next Article in Special Issue
The Prognostic Value of Liquid Biopsies for Benefit of Salvage Radiotherapy in Relapsed Oligometastatic Prostate Cancer
Previous Article in Journal / Special Issue
Proteomic Analysis of Prostate Cancer FFPE Samples Reveals Markers of Disease Progression and Aggressiveness
 
 
Article

Article Versions Notes

Cancers 2022, 14(15), 3766; https://doi.org/10.3390/cancers14153766
Action Date Notes Link
article xml file uploaded 2 August 2022 16:02 CEST Original file -
article xml uploaded. 2 August 2022 16:02 CEST Update -
article pdf uploaded. 2 August 2022 16:02 CEST Version of Record https://www.mdpi.com/2072-6694/14/15/3766/pdf-vor
article html file updated 2 August 2022 16:04 CEST Original file -
article xml file uploaded 3 August 2022 03:05 CEST Update -
article xml uploaded. 3 August 2022 03:05 CEST Update https://www.mdpi.com/2072-6694/14/15/3766/xml
article pdf uploaded. 3 August 2022 03:05 CEST Updated version of record https://www.mdpi.com/2072-6694/14/15/3766/pdf
article html file updated 3 August 2022 03:06 CEST Update -
article html file updated 13 August 2022 05:16 CEST Update https://www.mdpi.com/2072-6694/14/15/3766/html
Back to TopTop